BioCryst Pharmaceuticals, Inc.
BCRX
$9.81
$0.657.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.07% | -18.14% | -11.88% | -8.03% | -2.78% |
| Total Receivables | 16.96% | 0.16% | -2.37% | 18.12% | 9.13% |
| Inventory | 3.17% | 3.73% | -26.61% | -15.01% | 6.94% |
| Prepaid Expenses | 4.12% | 31.58% | -12.47% | 4.18% | -15.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -99.32% | 0.30% | 10,093.13% | 38.57% | -74.17% |
| Total Current Assets | 13.68% | -10.74% | -2.81% | -2.84% | -1.21% |
|
|
|||||
| Total Current Assets | 13.68% | -10.74% | -2.81% | -2.84% | -1.21% |
| Net Property, Plant & Equipment | -1.30% | -3.83% | 2.19% | -1.06% | 0.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.83% | 11.23% | -4.42% | 5.66% | 13.05% |
| Total Assets | 15.17% | -2.35% | -4.76% | -2.12% | -0.17% |
|
|
|||||
| Total Accounts Payable | 184.28% | -35.18% | -14.53% | -13.70% | -13.63% |
| Total Accrued Expenses | 6.43% | 10.89% | 15.63% | -18.23% | 8.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.56% | 4.56% | 1.55% | 4.86% | -1.23% |
| Total Finance Division Other Current Liabilities | -47.99% | 11.45% | -- | -- | -- |
| Total Other Current Liabilities | -47.99% | 11.45% | -- | -- | -- |
| Total Current Liabilities | 3.06% | 7.38% | 26.67% | -12.80% | 4.44% |
|
|
|||||
| Total Current Liabilities | 3.06% | 7.38% | 26.67% | -12.80% | 4.44% |
| Long-Term Debt | -32.56% | -8.28% | -11.69% | -1.75% | -0.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.52% | -3.47% | 4.35% | 0.45% | -0.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -3.96% | -- | -- | -- |
| Total Liabilities | -24.09% | -5.06% | -5.71% | -3.56% | 0.68% |
|
|
|||||
| Common Stock & APIC | 1.76% | 1.59% | 1.88% | 1.84% | 1.63% |
| Retained Earnings | 14.03% | 0.73% | 0.29% | 0.00% | -1.54% |
| Treasury Stock & Other | -96.67% | -30.74% | 45.41% | 22.91% | -59.83% |
| Total Common Equity | 69.28% | 7.99% | 6.71% | 5.04% | -1.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 69.28% | 7.99% | 6.71% | 5.04% | -1.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 69.28% | 7.99% | 6.71% | 5.04% | -1.57% |
|
|
|||||